GlassScriptPhysician profile
Mark W Hosking
NPI 1306103163
$18,567.19
in general payments reported to CMS, 2019-2025
31 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,569 · 2020: $226 · 2021: $3,483 · 2022: $4,946 · 2023: $7,135 · 2024: $535 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,484 · Food and Beverage: $1,986 · Travel and Lodging: $1,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,484.27 |
| Food and Beverage | $1,986.05 |
| Travel and Lodging | $1,872.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $12,013.69 | 2021-2023 | Peca-C Compressive Implants, Apollo Ankle Fracture Plating System, Creed Ortholocent Implants |
| Vilex LLC | $1,886.37 | 2023 | |
| Wright Medical Technology, INC. | $1,502.55 | 2019 | |
| Smith+Nephew, INC. | $1,065.70 | 2019-2025 | Collagenase Santyl, Grafix Pl, Stravix |
| Treace Medical Concepts, INC. | $509.31 | 2023-2025 | |
| Kerecis Limited | $177.73 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bioventus LLC | $119.93 | 2021-2023 | Sonicone Clinic |
| Abbvie INC. | $118.42 | 2022-2023 | |
| Organogenesis INC. | $117.14 | 2021-2024 | Puraply |
| Paragon 28, INC. | $106.63 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $105.95 | 2020-2025 | Tapestry |
| Grt US Holding, INC. | $90.50 | 2022 | |
| Linvatec Corporation | $85.51 | 2023 | Colink 2, Allograft Tissue, Biobrace 23mm |
| Averitas Pharma INC. | $78.67 | 2023-2024 | Qutenza |
| Orthofix Medical, INC. | $76.80 | 2019-2025 | Physio-Stim, Spinal-Stim |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $67.30 | 2020-2025 | Tcc-Ez |
| Stryker Corporation | $60.15 | 2022 | |
| Paratek Pharmaceuticals, INC. | $53.17 | 2025 | Nuzyra |
| Convatec INC. | $49.87 | 2022-2024 | |
| Hartmann USA, INC. | $41.36 | 2023 | Zetuvit Plus |
| Kci USA, INC. | $35.00 | 2021-2023 | Snap, V.A.C. Dermatac, Activ.A.C. |
| Tactile Systems Technology INC | $27.89 | 2025 | Nimbl, Flexitouch Plus |
| Inari Medical, INC. | $23.09 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Melinta Therapeutics, LLC | $22.28 | 2023 | Vabomere, Orbactiv, Kimyrsa |
| Solventum Corporation | $22.13 | 2025 | Activ.A.C. |
| Embody, INC. | $21.72 | 2022 | |
| Mimedx Group, INC. | $21.12 | 2025 | |
| Horizon Therapeutics Plc | $20.02 | 2022 | |
| Lifenet Health | $18.33 | 2023 | |
| Nevro Corp. | $15.62 | 2022 | |
| Ovik Health, LLC | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hosking listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.